Gilead seeks U.S. approval for COVID-19 treatment remdesivir
Go back to Gilead seeks U.S. approval for COVID-19 treatment remdesivir| Gilead Sciences (NASDAQ: GILD) | Delayed: 143.72 -1.09 (0.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $144.81 | 52 Week High | $108.63 | |||
| Open | $145.24 | 52 Week Low | $71.39 | |||
| Day High | $145.99 | P/E | 79.40 | |||
| Day Low | $143.50 | EPS | $1.81 | |||
| Volume | 4,202,403 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.72 +0.07 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.65 | 52 Week High | $37.39 | |||
| Open | $27.80 | 52 Week Low | $28.25 | |||
| Day High | $27.85 | P/E | 16.80 | |||
| Day Low | $27.42 | EPS | $1.65 | |||
| Volume | 25,534,238 | |||||
